Advanced Enzyme Technologies Ltd has announced a positive clinical breakthrough in randomized controlled trials involving systemic enzymes and probiotics aimed at alleviating long COVID fatigue symptoms. The trials involved two groups of patients, with one receiving the supplements and the other a placebo, showing significant efficacy in reducing fatigue.
Advanced Enzyme Technologies Limited has informed the Exchange regarding a press release dated September 13, 2021, titled " Advanced Enzymes announces Positive Clinical Breakthrough in the Randomized Controlled Trials of Systemic Enzymes and Probiotics to Resolve Long Covid Fatigue Symptoms ".